Recommended Pages at drugdevelopment-technology.com
Genentech reports non-inferior data of Actemra SC formulation - Drug Development Technology
drugdevelopment-technology.com — “Genentech's subcutaneous (SC) formulation of Actemra (tocilizumab) has met the primary endpoints of the Summacta study in adult patients with moderately to severely active rheumatoid arthritis (RA).Actemra is the first humanised IL-6...” View full resource at drugdevelopment-technology.com
Most Recently Shared on May 4, 2012 at 6:36 pm By:
Genentech reports non-inferior data of Actemra SC formulation: Genentech's subcutaneous (SC) formulation of Acte... http://t.co/3a4mqr0F
Zelboraf (vemurafenib) Tablets – Treatment for Metastatic Melanoma - Drug Development Technology
drugdevelopment-technology.com — “Zelboraf is a drug indicated for the treatment of Metastatic Melanoma. The drug was developed by Plexxikon in collaboration with Roche. Plexxikon was acquired by Daiichi Sankyo in April 2011.Genentech, a member of the Roche Group, submitted a new...” View full resource at drugdevelopment-technology.com
Most Recently Shared on October 19, 2011 at 10:30 pm By:
Zelboraf (vemurafenib) Tablets – Treatment for Metastatic Melanoma: Zelboraf is a drug indicated for the treat... http://t.co/kfeyDGsz
Trobalt / Potiga – Treatment for Partial-Onset Seizure - Drug Development Technology
drugdevelopment-technology.com — “Trobalt (Ezogabine / Retigabine) is indicated for the treatment of partial-onset epileptic seizures in patients aged more than 18 years old. It is being developed and manufactured jointly by Canada-based Valeant Pharmaceuticals and...” View full resource at drugdevelopment-technology.com
Most Recently Shared on September 28, 2011 at 5:26 pm By:
Trobalt / Potiga – Treatment for Partial-Onset Seizure: Trobalt (Ezogabine / Retigabine) is indicated for the ... http://t.co/9rqjiggX
Tissue Solutions Introduces Exciting New Human Hepatoma Cell Line - Drug Development Technology
drugdevelopment-technology.com — “Tissue Solutions Introduces Exciting New Human Hepatoma Cell Line - Drug Development Technology” View full resource at drugdevelopment-technology.com
Most Recently Shared on August 25, 2011 at 6:10 am By:
Tissue Solutions Introduces Exciting New Human Hepatoma Cell Line: Tissue Solutions is pleased to offer an excit... http://t.co/5Xyk85H
Drug Development Technology - Research Grants Awarded for Frontotemporal Dementia
drugdevelopment-technology.com — “Drug Development Technology - Research Grants Awarded for Frontotemporal Dementia” View full resource at drugdevelopment-technology.com
Most Recently Shared on April 16, 2010 at 4:26 pm By:
Shelley Webb Nurse, Eldercare Expert, and Active Health Library
Research Grants Awarded for Frontotemporal Dementia. http://ow.ly/1zndH #drug #healthcare #pharmaceutical (via @Pharma_Tech)
